Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GRASP55 plays a key physiological role in intestinal lipid uptake

April 7, 2020

European Commission approves Rybelsus for type 2 diabetes

April 6, 2020

Crinetics Pharmaceuticals presents somatostatin SST2 receptor agonists

April 3, 2020

Females, males have different metabolic response to intermittent fasting

April 3, 2020

New melanocortin MC4 receptor agonists synthesized at Novo Nordisk

March 31, 2020

Lamin A/C's presence in nucleus, absence from membrane both problematic in progeria

March 31, 2020

NGM studies NGM-395 in obese adults and patients with NAFLD

March 30, 2020

Caelum initiates phase II study of CAEL-101 in AL amyloidosis

March 30, 2020

Sanofi receives approval for Soliqua, a combination agent to treat type 2 diabetes, in Japan

March 26, 2020

Multistep method wrests causality from GWAS

March 26, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...